Brain Training for Opioid Use Disorder
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Research shows that neurofeedback, a component of Bias Modification Biofeedback, has been effective in reducing symptoms and cravings in opioid-dependent patients. Additionally, neurofeedback has shown benefits in improving impulsivity and attention deficits in individuals with substance use disorders, suggesting its potential usefulness in treating opioid use disorder.
12345Neurofeedback, a type of brain training, has been used safely in studies with people who have substance use disorders, including those dependent on opioids. These studies did not report any major safety concerns, suggesting that this treatment is generally safe for humans.
12467Bias Modification Biofeedback is unique because it uses real-time feedback to help patients change their brain responses to drug-related cues, aiming to reduce cravings and prevent relapse. This approach is different from traditional treatments that often focus on medication or behavioral therapy alone, as it directly targets the brain's response patterns associated with addiction.
12368Eligibility Criteria
This trial is for individuals with Opioid Use Disorder (OUD) who are in treatment and can consent to follow-ups. Control participants must match an OUD patient by age and gender, have at least a 6th grade reading level, and no opioid or serious drug issues. Exclusions include pregnancy, inability to consent, poor vision for computer tasks, regular nicotine use within the past year, unwillingness to adjust hair for EEG headset application, or serious neurological conditions.Inclusion Criteria
Exclusion Criteria